Clinical Trial Update: Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating pharmacokinetics, pharmacodynamics, and tolerance of P03277 in healthy volunteers and patients with brain lesions has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Lesion

Drugs mentioned

• P03277

Snippet

Sponsor: Guerbet | Conditions: Healthy Volunteers, Brain Lesion | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-12